Innate Lymphoid Cells in Skin Homeostasis and Malignancy

Innate lymphoid cells (ILCs) are mostly tissue resident lymphocytes that are preferentially enriched in barrier tissues such as the skin. Although they lack the expression of somatically rearranged antigen receptors present on T and B cells, ILCs partake in multiple immune pathways by regulating tis...

Full description

Bibliographic Details
Main Authors: Marek Wagner, Shigeo Koyasu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.758522/full
id doaj-9e6611efe45b4ca68588da5b243b22e4
record_format Article
spelling doaj-9e6611efe45b4ca68588da5b243b22e42021-10-08T06:34:12ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-10-011210.3389/fimmu.2021.758522758522Innate Lymphoid Cells in Skin Homeostasis and MalignancyMarek Wagner0Marek Wagner1Shigeo Koyasu2Laboratory for Immune Cell Systems, RIKEN Center for Integrative Medical Sciences, Yokohama, JapanDepartment of Biomedicine, University of Bergen, Bergen, NorwayLaboratory for Immune Cell Systems, RIKEN Center for Integrative Medical Sciences, Yokohama, JapanInnate lymphoid cells (ILCs) are mostly tissue resident lymphocytes that are preferentially enriched in barrier tissues such as the skin. Although they lack the expression of somatically rearranged antigen receptors present on T and B cells, ILCs partake in multiple immune pathways by regulating tissue inflammation and potentiating adaptive immunity. Emerging evidence indicates that ILCs play a critical role in the control of melanoma, a type of skin malignancy thought to trigger immunity mediated mainly by adaptive immune responses. Here, we compile our current understanding of ILCs with regard to their role as the first line of defence against melanoma development and progression. We also discuss areas that merit further investigation. We envisage that the possibility to harness therapeutic potential of ILCs might benefit patients suffering from skin malignancies such as melanoma.https://www.frontiersin.org/articles/10.3389/fimmu.2021.758522/fullinnate lymphoid cellsskinskin cancermelanomaimmunityimmunosurveillance
collection DOAJ
language English
format Article
sources DOAJ
author Marek Wagner
Marek Wagner
Shigeo Koyasu
spellingShingle Marek Wagner
Marek Wagner
Shigeo Koyasu
Innate Lymphoid Cells in Skin Homeostasis and Malignancy
Frontiers in Immunology
innate lymphoid cells
skin
skin cancer
melanoma
immunity
immunosurveillance
author_facet Marek Wagner
Marek Wagner
Shigeo Koyasu
author_sort Marek Wagner
title Innate Lymphoid Cells in Skin Homeostasis and Malignancy
title_short Innate Lymphoid Cells in Skin Homeostasis and Malignancy
title_full Innate Lymphoid Cells in Skin Homeostasis and Malignancy
title_fullStr Innate Lymphoid Cells in Skin Homeostasis and Malignancy
title_full_unstemmed Innate Lymphoid Cells in Skin Homeostasis and Malignancy
title_sort innate lymphoid cells in skin homeostasis and malignancy
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-10-01
description Innate lymphoid cells (ILCs) are mostly tissue resident lymphocytes that are preferentially enriched in barrier tissues such as the skin. Although they lack the expression of somatically rearranged antigen receptors present on T and B cells, ILCs partake in multiple immune pathways by regulating tissue inflammation and potentiating adaptive immunity. Emerging evidence indicates that ILCs play a critical role in the control of melanoma, a type of skin malignancy thought to trigger immunity mediated mainly by adaptive immune responses. Here, we compile our current understanding of ILCs with regard to their role as the first line of defence against melanoma development and progression. We also discuss areas that merit further investigation. We envisage that the possibility to harness therapeutic potential of ILCs might benefit patients suffering from skin malignancies such as melanoma.
topic innate lymphoid cells
skin
skin cancer
melanoma
immunity
immunosurveillance
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.758522/full
work_keys_str_mv AT marekwagner innatelymphoidcellsinskinhomeostasisandmalignancy
AT marekwagner innatelymphoidcellsinskinhomeostasisandmalignancy
AT shigeokoyasu innatelymphoidcellsinskinhomeostasisandmalignancy
_version_ 1716838679905828864